Small Molecule Therapy Targeting POLA1 to Treat Cancer @UniversityHospitals
Small Molecule Therapy Targeting POLA1 to Treat Cancer @UniversityHospitals
Uploaded April 2026 | Updated September 2026, 1 week ago
Deepak Nijhawan, MD, PhD, UT Southwestern, 2017 Harrington Scholar-Innovator, is advancing a first-in-class small molecule therapy that targets POLA1, a key enzyme in DNA replication, with the goal of creating a powerful new treatment option for patients with cancer.

Harrington Discovery Institute at University Hospitals in Cleveland, Ohio aims to accelerate promising discoveries into medicines for unmet needs. Learn more: HarringtonDiscovery.org.
Small Molecule Therapy Targeting POLA1 to Treat CancerGo Red for Women Feature: Teen Daughter Saves Moms Life with CPRUniversity Hospitals Research & Innovation Day - Brian Appleby, MDRight Care, Right Place: Creating Stronger CommunitiesMohamed Elkasaby, MD - NeurologyA Regional Powerhouse for Cancer Discovery and Patient ImpactUniversity Hospitals Health Services Research Grand Rounds with Heather Tubbs Cooley, PhD, RNUniversity Hospitals Global Health Grand Rounds with Melissa Bauserman, MD.Developing an RNA Therapy for Rare Hereditary Nerve DiseaseScrolling, Stress and the Teenage Brain: How EEG Biomarkers and Self-Management Can Change the StoryOvarian Tissue Transplants Provide New Hope to Women with Ovarian InsufficiencyGreat care - UH Seidman Cancer Center
University Hospitals |

Small Molecule Therapy Targeting POLA1 to Treat Cancer

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER